메뉴 건너뛰기




Volumn 34, Issue 6, 1996, Pages 359-366

Substituting traditional antipsychotics with risperidone for individuals with mental retardation

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; LOXAPINE; MESORIDAZINE; MOLINDONE; NEUROLEPTIC AGENT; RISPERIDONE; THIORIDAZINE;

EID: 0030462937     PISSN: 00476765     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (23)

References (17)
  • 1
    • 0342674305 scopus 로고
    • Psychoactive drugs in mental retardation
    • J. L. Matson & F. Andrasik (Eds.), New York: Plenum Press
    • Aman, M. G. (1983). Psychoactive drugs in mental retardation. In J. L. Matson & F. Andrasik (Eds.), Treatment issues and innovations in mental retardation (pp. 455-513). New York: Plenum Press.
    • (1983) Treatment Issues and Innovations in Mental Retardation , pp. 455-513
    • Aman, M.G.1
  • 2
    • 0001824107 scopus 로고
    • Patterns of drug use, methodological considerations, measurement techniques, and future trends
    • M. G. Aman & N. N. Singh (Eds.), New York: Springer-Verlag
    • Aman, M. G., & Singh, N. N. (1988). Patterns of drug use, methodological considerations, measurement techniques, and future trends. In M. G. Aman & N. N. Singh (Eds.), Psychopharmacology of the developmental disabilities (pp. 1-28). New York: Springer-Verlag.
    • (1988) Psychopharmacology of the Developmental Disabilities , pp. 1-28
    • Aman, M.G.1    Singh, N.N.2
  • 3
    • 0002444784 scopus 로고
    • Pharmacological interventions
    • J. L. Matson & J. A. Mulick (Eds.), New York: Pergamon Press
    • Aman, M. G., & Singh, N. N. (1991). Pharmacological interventions. In J. L. Matson & J. A. Mulick (Eds.), Handbook of mental retardation (pp. 347-372). New York: Pergamon Press.
    • (1991) Handbook of Mental Retardation , pp. 347-372
    • Aman, M.G.1    Singh, N.N.2
  • 5
    • 0028096538 scopus 로고
    • Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia
    • Grant, S., & Fitton, A. (1994). Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs, 48, 253-273.
    • (1994) Drugs , vol.48 , pp. 253-273
    • Grant, S.1    Fitton, A.2
  • 7
    • 0029026941 scopus 로고
    • The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A PET study
    • Kapur, S., Remington, G., Zipursky, R. B., Wilson, A. A., & Houle, S. (1995) The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A PET study. Life Sciences, 57, 103-107.
    • (1995) Life Sciences , vol.57 , pp. 103-107
    • Kapur, S.1    Remington, G.2    Zipursky, R.B.3    Wilson, A.A.4    Houle, S.5
  • 8
    • 0027318059 scopus 로고
    • Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: Role of 5HT2 receptors
    • Leysen, J. E., Janssen, P. M., Schotte, A., Luyten, W. H., &. Megens, A. A. (1993). Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: Role of 5HT2 receptors. Psychopharmacology, 112, S40-S54.
    • (1993) Psychopharmacology , vol.112
    • Leysen, J.E.1    Janssen, P.M.2    Schotte, A.3    Luyten, W.H.4    Megens, A.A.5
  • 11
    • 0019171263 scopus 로고
    • Diagnosis of psychiatric disorder in the severely and profoundly retarded patient
    • Reid, A. H. (1980). Diagnosis of psychiatric disorder in the severely and profoundly retarded patient. Journal of the Royal Society of Medicine, 73, 607-609.
    • (1980) Journal of the Royal Society of Medicine , vol.73 , pp. 607-609
    • Reid, A.H.1
  • 12
    • 0010165474 scopus 로고
    • Neuroleptic medications for persons with developmental disabilities
    • M. G. Aman & N. N. Singh (Eds.), New York: Springer-Verlag
    • Schroeder, S. R. (1988). Neuroleptic medications for persons with developmental disabilities. In M. G. Aman & N. N. Singh (Eds.), Psychopharmacology of the developmental disabilities (pp. 82-100). New York: Springer-Verlag.
    • (1988) Psychopharmacology of the Developmental Disabilities , pp. 82-100
    • Schroeder, S.R.1
  • 13
  • 14
    • 0023037341 scopus 로고
    • Limiting factors in the use of DSM-III criteria with mentally ill/mentally retarded persons
    • Sovner, R. (1986). Limiting factors in the use of DSM-III criteria with mentally ill/mentally retarded persons. Psychopharmacology Bulletin, 22, 1055-1059.
    • (1986) Psychopharmacology Bulletin , vol.22 , pp. 1055-1059
    • Sovner, R.1
  • 16
    • 0027478425 scopus 로고
    • Risperidone as add-on therapy in behavioral disturbances in mental retardation: A double blind placebo-controlled cross-over study
    • Vanden Borre, R., Vermote, R., Buttiens, M., Thiry, P., Geutjens, J., Sieben, G., & Heylen, S. (1993). Risperidone as add-on therapy in behavioral disturbances in mental retardation: A double blind placebo-controlled cross-over study. Acta Psychiatrica Scandanavica, 87, 167-171.
    • (1993) Acta Psychiatrica Scandanavica , vol.87 , pp. 167-171
    • Vanden Borre, R.1    Vermote, R.2    Buttiens, M.3    Thiry, P.4    Geutjens, J.5    Sieben, G.6    Heylen, S.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.